Bedaquiline and India's patent law

Opposition to the new patent claims on the Johnson & Johnson drug is a test of how well the rules against evergreening are working

Indian company gets licence to manufacture and sell patented cancer drug

This is the first-ever compulsory licence given to a generic drug company